PMC:13912 / 2492-3253 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/13912","sourcedb":"PMC","sourceid":"13912","source_url":"http://www.ncbi.nlm.nih.gov/pmc/13912","text":"al differences cannot be excluded.\n\nAims:\nThe goal of this study was to investigate the expressions of ERC4, \t\t\t\tERD5 and ERD3 variant messenger RNAs in normal breast tissues and their matched \t\t\t\tadjacent primary breast tumor tissues.\n\nMaterials and methods:\nEighteen cases were selected from the Manitoba Breast Tumor Bank, \t\t\t\twhich had well separated and histopathologically characterized normal and \t\t\t\tadjacent neoplastic components. All tumors were classified as primary invasive \t\t\t\tductal carcinomas. Six tumors were ER-negative/progesterone receptor \t\t\t\t(PR)-negative, nine were ER-positive/PR-positive, two were \t\t\t\tER-positive/PR-negative, and one was ER-negative/PR-positive, as measured by \t\t\t\tligand-binding assay. For each specimen, total RNA wa","divisions":[{"label":"Section","span":{"begin":36,"end":235}},{"label":"Title","span":{"begin":36,"end":41}},{"label":"Title","span":{"begin":237,"end":259}}],"tracks":[]}